医药代表备案证件,重要信息公开了

2019-11-18 整理:玉米 医药代表/赛柏蓝

三甲医院医药代表证,公开了。

三甲医院医药代表证,公开了。

医药代表证,公开重要信息

日前,据医药代表公众号消息,云南省中医医院(云南中医药大学第一附属医院)发布通知,在医院从业活动的医药代表必须进行备案。

公开资料显示,云南省中医医院(云南中医药大学第一附属医院)始建于1947年,是一所集医疗、教学、科研、康复于一体的三级甲等综合性中医医院。据悉在这家医院备案,医药代表要提供身份证明、学历、专业、医药领域从业经历证明等资料。

值得注意的是,在医药代表证模板上,将会有医药代表名字、身份证号、公司名称、负责推广药品名称的信息。

医药代表备案,全国推行

2017年12年22日原食药总局、国家卫计委联合发布《医药代表登记备案管理办法(试行)(征求意见稿)》,规定医药代表须由药品上市许可持有人负责平台备案,这个文件对需要备案的医药代表有着学历、工作经验上的要求。

从此后公布的多家医院医药备案要求来看, 基本上遵循了国家对医药代表备案的整体要求。如广西卫生健康委发布《广西壮族自治区卫生健康行业作风建设工作方案》要求医药代表全部备案。

备案时,医药代表登记的事项,包括姓名、性别、身份证号码、学历水平、从业年数、联系电话,以及所属药品生产企业的名称、工商住所地、法定代表人名称等事项,此外浙江等医院的备案也有着同样的要求。

目前医院对医药代表在医院的推广活动限制越来越严,此前有报道某医院要求合作供应商的各类工作人员及销售代表拍摄个人照片工作。有迹象表明医药代表在医院将会处于视频监控中,一旦发现出现在诊疗区域,将会被驱逐。

备案,增加职业价值感

这种措施还是出于监管部门对医药商业贿赂的高压,严格规范医学协(学)会、医疗机构、医务人员与医药相关企业间的学术会议、科研协作、学术支持、捐赠资助行为,严惩供销链条违法犯罪。

目前来看,对医药商业贿赂的打击已经有了积极的意义,不少药企和代理商都正在积极转型,当然这其中也有财税方面的压力。整体看,这种高压推动了行业营销模式的转型。

回到医药代表备案的规定,一方面是从形式上对推广人员形成约束,同时也有警示的作用。备案也表明这个职业正在逐步走向规范,正如有医药代表认为,希望早点备案,这份工作的价值感会更强。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1666748, encodeId=efe51666e48b7, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Fri Jan 10 19:44:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409937, encodeId=6093140993e7e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443615, encodeId=fd0614436156e, content=<a href='/topic/show?id=eaf6352e26e' target=_blank style='color:#2F92EE;'>#医药代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35272, encryptionId=eaf6352e26e, topicName=医药代表)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUnmV4MWxxicaHm4w2E4EPicofrVHWChQPKibnOtt8t8j7jYGkdKxNvF0KkC2sDXw04QS2GS2UUBSLg/132, createdBy=5cc15086507, createdName=ms9203727104890838, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590974, encodeId=a35e15909e40d, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]
    2020-01-10 fengyqf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1666748, encodeId=efe51666e48b7, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Fri Jan 10 19:44:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409937, encodeId=6093140993e7e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443615, encodeId=fd0614436156e, content=<a href='/topic/show?id=eaf6352e26e' target=_blank style='color:#2F92EE;'>#医药代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35272, encryptionId=eaf6352e26e, topicName=医药代表)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUnmV4MWxxicaHm4w2E4EPicofrVHWChQPKibnOtt8t8j7jYGkdKxNvF0KkC2sDXw04QS2GS2UUBSLg/132, createdBy=5cc15086507, createdName=ms9203727104890838, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590974, encodeId=a35e15909e40d, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]
    2019-11-20 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=1666748, encodeId=efe51666e48b7, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Fri Jan 10 19:44:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409937, encodeId=6093140993e7e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443615, encodeId=fd0614436156e, content=<a href='/topic/show?id=eaf6352e26e' target=_blank style='color:#2F92EE;'>#医药代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35272, encryptionId=eaf6352e26e, topicName=医药代表)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUnmV4MWxxicaHm4w2E4EPicofrVHWChQPKibnOtt8t8j7jYGkdKxNvF0KkC2sDXw04QS2GS2UUBSLg/132, createdBy=5cc15086507, createdName=ms9203727104890838, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590974, encodeId=a35e15909e40d, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1666748, encodeId=efe51666e48b7, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87287, encryptionId=df6a8e287d7, topicName=药代)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bccf26064950, createdName=fengyqf, createdTime=Fri Jan 10 19:44:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409937, encodeId=6093140993e7e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443615, encodeId=fd0614436156e, content=<a href='/topic/show?id=eaf6352e26e' target=_blank style='color:#2F92EE;'>#医药代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35272, encryptionId=eaf6352e26e, topicName=医药代表)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUnmV4MWxxicaHm4w2E4EPicofrVHWChQPKibnOtt8t8j7jYGkdKxNvF0KkC2sDXw04QS2GS2UUBSLg/132, createdBy=5cc15086507, createdName=ms9203727104890838, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590974, encodeId=a35e15909e40d, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Wed Nov 20 04:44:00 CST 2019, time=2019-11-20, status=1, ipAttribution=)]
    2019-11-20 cenghis

相关资讯

医药代表的收入,减少了吗?

4+7带量采购给药企带来的震荡此起彼伏,4+7全国扩面紧随其后。带量采购实行以来,怎样改变药企营销呢?

药品集采扩面之后,医药代表的战略价值

全国带量采购的大戏既已开场,后面的事不难想象,也无需想象:未中标的产品,失去了准入机会,没有业绩,所以没戏;中标的产品,有业绩,但没空间,所以也没戏。

日本发布《2019年医药代表白皮书》

近日,日本MR认证中心发布了《2019年版医药代表白皮书》,截至今年 3月底,日本医药代表总人数为59900人。

全国4+7后,医药代表要跳槽了

带量采购全国铺开,大批医药代表开始跳槽。

两三甲医院,通知医药代表备案

两所三甲医院,通知医药代表备案。

央视曝光!一批医药代表被抓

有药械代表和黑客组队作案了...